Selected research
Industry Growth & Trends
Global Monogenic Disease Testing Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Monogenic Disease Testing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Monogenic Disease Testing is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Monogenic Disease Testing is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Monogenic Disease Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Monogenic Disease Testing market include Celera Support Services, Abbott, ELITech Group, Auto Genomics, PerkinElmer and Bio-Rad Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Monogenic Disease Testing market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Monogenic Disease Testing market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Monogenic Disease Testing market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Monogenic Disease Testing.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Monogenic Disease Testing market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Monogenic Disease Testing Market by Company
Celera Support Services
Abbott
ELITech Group
Auto Genomics
PerkinElmer
Bio-Rad Laboratories
Monogenic Disease Testing Segment by Type
Carrier Testing
Diagnostic Testing
New-Born Screening
Predictive and Pre-Symptomatic Testing
Prenatal Testing
Monogenic Disease Testing Segment by Application
Hospitals
Clinics
Others
Monogenic Disease Testing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Monogenic Disease Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Monogenic Disease Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Monogenic Disease Testing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Monogenic Disease Testing companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Carrier Testing
- Diagnostic Testing
- New-Born Screening
- Predictive and Pre-Symptomatic Testing
- Prenatal Testing
Applications
- Hospitals
- Clinics
- Others
Companies covered
- Celera Support Services
- Abbott
- ELITech Group
- Auto Genomics
- PerkinElmer
- Bio-Rad Laboratories
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Monogenic Disease Testing Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Monogenic Disease Testing Market Size by Region (2021-2032)
- 1.4.1 Global Monogenic Disease Testing Market Size by Region (2021-2026)
- 1.4.2 Global Monogenic Disease Testing Market Size by Region (2027-2032)
- 1.5 Key Regions Monogenic Disease Testing Market Size (2021-2032)
- 1.5.1 North America Monogenic Disease Testing Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Monogenic Disease Testing Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Monogenic Disease Testing Market Size Growth Rate (2021-2032)
- 1.5.4 South America Monogenic Disease Testing Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Monogenic Disease Testing Market Size Growth Rate (2021-2032)
2 Monogenic Disease Testing Market by Type
- 2.1 Type Introduction
- 2.1.1 Carrier Testing
- 2.1.2 Diagnostic Testing
- 2.1.3 New-Born Screening
- 2.1.4 Predictive and Pre-Symptomatic Testing
- 2.1.5 Prenatal Testing
- 2.2 Global Monogenic Disease Testing Market Size by Type
- 2.2.1 Global Monogenic Disease Testing Market Size Overview by Type (2021-2032)
- 2.2.2 Global Monogenic Disease Testing Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Monogenic Disease Testing Market Size Forecasted by Type (2027-2032)
- 2.3 Global Monogenic Disease Testing Market Size by Regions
- 2.3.1 North America Monogenic Disease Testing Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Monogenic Disease Testing Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Monogenic Disease Testing Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Monogenic Disease Testing Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Monogenic Disease Testing Market Size Breakdown by Type (2021-2026)
3 Monogenic Disease Testing Market by Application
- 3.1 Type Introduction
- 3.1.1 Hospitals
- 3.1.2 Clinics
- 3.1.3 Others
- 3.2 Global Monogenic Disease Testing Market Size by Application
- 3.2.1 Global Monogenic Disease Testing Market Size Overview by Application (2021-2032)
- 3.2.2 Global Monogenic Disease Testing Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Monogenic Disease Testing Market Size Forecasted by Application (2027-2032)
- 3.3 Global Monogenic Disease Testing Market Size by Regions
- 3.3.1 North America Monogenic Disease Testing Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Monogenic Disease Testing Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Monogenic Disease Testing Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Monogenic Disease Testing Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Monogenic Disease Testing Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Monogenic Disease Testing Industry Trends
- 4.2 Monogenic Disease Testing Industry Drivers
- 4.3 Monogenic Disease Testing Industry Opportunities and Challenges
- 4.4 Monogenic Disease Testing Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Monogenic Disease Testing Revenue (2021-2026)
- 5.2 Global Monogenic Disease Testing Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Monogenic Disease Testing Key Company Headquarters & Area Served
- 5.4 Global Monogenic Disease Testing Company, Product Type & Application
- 5.5 Global Monogenic Disease Testing Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Monogenic Disease Testing Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Monogenic Disease Testing Players Market Share by Revenue in 2025
- 5.6.3 2025 Monogenic Disease Testing Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Celera Support Services
- 6.1.1 Celera Support Services Company Information
- 6.1.2 Celera Support Services Business Overview
- 6.1.3 Celera Support Services Monogenic Disease Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Celera Support Services Monogenic Disease Testing Product Portfolio
- 6.1.5 Celera Support Services Recent Developments
- 6.2 Abbott
- 6.2.1 Abbott Company Information
- 6.2.2 Abbott Business Overview
- 6.2.3 Abbott Monogenic Disease Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Abbott Monogenic Disease Testing Product Portfolio
- 6.2.5 Abbott Recent Developments
- 6.3 ELITech Group
- 6.3.1 ELITech Group Company Information
- 6.3.2 ELITech Group Business Overview
- 6.3.3 ELITech Group Monogenic Disease Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 ELITech Group Monogenic Disease Testing Product Portfolio
- 6.3.5 ELITech Group Recent Developments
- 6.4 Auto Genomics
- 6.4.1 Auto Genomics Company Information
- 6.4.2 Auto Genomics Business Overview
- 6.4.3 Auto Genomics Monogenic Disease Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Auto Genomics Monogenic Disease Testing Product Portfolio
- 6.4.5 Auto Genomics Recent Developments
- 6.5 PerkinElmer
- 6.5.1 PerkinElmer Company Information
- 6.5.2 PerkinElmer Business Overview
- 6.5.3 PerkinElmer Monogenic Disease Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 PerkinElmer Monogenic Disease Testing Product Portfolio
- 6.5.5 PerkinElmer Recent Developments
- 6.6 Bio-Rad Laboratories
- 6.6.1 Bio-Rad Laboratories Company Information
- 6.6.2 Bio-Rad Laboratories Business Overview
- 6.6.3 Bio-Rad Laboratories Monogenic Disease Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Bio-Rad Laboratories Monogenic Disease Testing Product Portfolio
- 6.6.5 Bio-Rad Laboratories Recent Developments
7 North America
- 7.1 North America Monogenic Disease Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Monogenic Disease Testing Market Size by Country (2021-2026)
- 7.3 North America Monogenic Disease Testing Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Monogenic Disease Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Monogenic Disease Testing Market Size by Country (2021-2026)
- 8.3 Europe Monogenic Disease Testing Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Monogenic Disease Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Monogenic Disease Testing Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Monogenic Disease Testing Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Monogenic Disease Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Monogenic Disease Testing Market Size by Country (2021-2026)
- 10.3 South America Monogenic Disease Testing Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Monogenic Disease Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Monogenic Disease Testing Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Monogenic Disease Testing Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst